SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending following its preliminary Q3 revenue exceeding expectations, sparking a surge of investor enthusiasm. The community is actively discussing the company's substantial year-over-year growth and its reinforced position as a crucial 'picks and shovels' provider for the expanding AI data center infrastructure.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) is experiencing an intense sell-off and community debate following the abrupt departures of its CFO and general counsel amid an ongoing accounting review, delayed regulatory filings, and reduced financial guidance. While many see the over 50% plunge as an extreme overreaction and a potential buying opportunity, others express deep concern over financial irregularities, referencing a past short report, and caution against further downside.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is generating strong community buzz as its AI-powered ecosystem expands with new exchange listings and cross-chain integrations, leading many to anticipate significant price milestones and further utility growth.

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc

Satellos Bioscience (MSLE) is trending following its recent NASDAQ listing and a significant $50 million financing, sparking intense debate around its novel Duchenne Muscular Dystrophy drug, SAT-3247. The community is split between those hailing its "revolutionary" muscle regeneration potential and acquisition prospects, and skeptics citing its early-stage data and concerns over dilution.

NexGen Energy Ltd. engages in the acquisition, exploration and development of uranium properties. Its uranium project portfolio includes Arrow, South Arrow, Harpoon, Bow, IsoEnergy, SW1, SW2, SW3, and IsoEnergy properties. The company was founded by Leigh B. Curyer on March 8, 2011 and is headquartered in Vancouver, Canada.

NexGen Energy Ltd

NexGen Energy (NXE) is trending following a critical short report from Culper Research that challenged its valuation and production capabilities, sparking a strong defense from the community. Investors are refuting the report's claims, underscoring the company's world-class uranium deposit and its strategic role in meeting rising global nuclear and AI-driven energy demand as it approaches key regulatory milestones.

Syntec Optics Holdings, Inc. engages in the design and manufacture of optics and photonics enabled products. The company was founded in 1981 and is headquartered in Rochester, NY.

Syntec Optics Holdings Inc. - Ordinary Shares - Class A

Syntec Optics Holdings Inc

Syntec Optics (OPTX) is gaining traction from new ballistic optics orders for U.S. military augmented reality systems and increasing demand for its space and AI data center optics. The community is actively debating its low float and significant growth potential from defense and AI tailwinds against concerns over its current valuation and cash position.

Symbotic, Inc. is an automation technology company, which engages in a robotics and automation-based product movement technology platform. It focuses on developing, commercializing, and deploying innovative, end-to-end technology solutions for supply chain operations. It operates through the United States and Canada geographical segments. The company was founded by Richard B. Cohen on December 11, 2020 and is headquartered in Wilmington, MA.

Symbotic Inc - Ordinary Shares - Class A

Symbotic Inc 

Symbotic is trending after reporting strong earnings that exceeded profit expectations and showed significant revenue growth, alongside a new healthcare customer deal. The community is actively discussing its sharp recovery after a volatile period marked by a secondary offering and a major analyst downgrade, emphasizing its long-term potential in AI robotics and warehouse automation despite ongoing valuation concerns.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Energy and Transportation, Financial Products, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Energy and Transportation segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The Financial Products segment provides financing alternatives to customers and dealers for Caterpillar products and services, as well as financing for power generation facilities. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925 and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is trending sharply higher after reporting strong results, with its energy and transportation segments seeing significant growth attributed to booming AI-driven data center demand. While bullish investors celebrate record backlogs and a market rotation into industrials, a vocal segment expresses skepticism about the valuation and potential for a significant pullback.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors react to the inauguration of its Eagle Line pilot production facility, signaling a crucial step towards scalable solid-state battery manufacturing. The community is actively debating whether this progress, including observed OEM presence, translates to imminent commercialization and new partnerships, or if skepticism over revenue and formal customer announcements will persist ahead of upcoming earnings.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Federal National Mortgage Association (FNMA) is trending amidst renewed speculation of an imminent uplisting to the NYSE or an IPO, fueled by recent comments from FHFA Director Pulte indicating readiness for a public offering and a brief appearance of an NYSE listing manual on Fannie Mae's website. The community remains divided between hopeful long-term investors anticipating significant returns and those expressing deep frustration over prolonged delays and political maneuvering surrounding the GSEs' future.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The stock posted its best session in nearly a month as investors looked ahead to quarterly results.</li><li>Wall Street expects quarter-on-quarter revenue growth, while losses are projected to widen.</li><li>The company has said previously that it remains confident of returning to profitability in 2026.</li></ul>Shares of Oscar Health, Inc. (OSCR) snapped a six-day losing streak on Monday as investors looked ahead to quarterly results expected to show steady revenue growth but widening losses.<a href="https://stocktwits.com/symbol/OSCR">OSCR stock</a> logged its best session in nearly a month on Monday to end at $12.66 and edged 2% higher in after-hours trading.&nbsp;<h2 class="st-heading-2">What Wall Street Expects From OSCR’s Q4 Print</h2>According to Koyfin estimates, Oscar is expected to report quarter-on-quarter revenue growth, with fourth-quarter (Q4) revenue at $3.12 billion, up from nearly $2.99 billion in the prior quarter.However, losses are expected to widen. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss is projected to&nbsp;balloon to $217.8 million&nbsp;from $101.5&nbsp;a year earlier. Earnings before interest and taxes (EBIT) loss is expected to widen to $234.7 million from $129.3 million, while GAAP loss per share is forecast at $0.86 per share, compared with a loss per share of $0.53 per share previously.&nbsp;OSCR stock carries a consensus 'Hold' rating, according to Koyfin. Of the 10 analysts covering the company, one rates it 'Strong Buy', none rate it 'Buy', six have 'Hold' ratings, two rate it 'Sell', and one rates it 'Strong Sell.'<h2 class="st-heading-2">Brokerage Views On OSCR Stock</h2>Last month, UBS upgraded Oscar to 'Neutral' from 'Sell' and raised its price target to $17 from $12, saying exchange enrollment has held up better than feared despite the expiration of enhanced premium subsidies. UBS added that the shares appear fairly valued at current levels.Around the same time, Barclays upgraded Oscar to 'Equal Weight' from 'Underweight' with an $18 price target. The firm said managed care stocks could benefit in 2026 from margin expansion and a rotation away from AI-linked stocks, adding that the market may be over-discounting the negative impact of expiring subsidies on Oscar.More bullish commentary came earlier from Piper Sandler, which upgraded Oscar to 'Overweight' in November and raised its price target to $25 following a deep dive into pricing, benefit design, and broker strategy in Miami-Dade County. Piper said Oscar could grow market share and improve profitability even if enhanced subsidies expire, and described&nbsp;the calendar year 2027 adjusted EBITDA of $404 million as a downside floor.Meanwhile, Jefferies maintained an 'Underperform' rating in December with a $12 price target, warning of elevated medical loss ratio risk tied to special enrollment periods, particularly in Georgia. Stephens, which initiated coverage in the same month with an 'Equal Weight' rating and a $17 target, described Oscar’s pure-play exposure to Affordable Care Act (ACA) exchanges as a “two-way street” that supports profitability initiatives but also adds uncertainty to longer-term growth.<h2 class="st-heading-2">ACA Enrollment Trends Remain A Key Overhang</h2>Oscar’s earnings come as ACA enrollment shows early signs of cooling. Data from the Centers for Medicare and Medicaid Services showed 2026 marketplace enrollment at about 22.8 million, down from 24.3 million the prior year, following the lapse of enhanced premium subsidies that had been in place since 2021.The subsidies had lifted total enrollment to above 24 million by 2025, after spending 11 million to 12 million from 2015 to 2021.&nbsp;However, on its November earnings call, Oscar said it was confident it could expand margins and return to profitability in 2026, citing disciplined pricing and geographic expansion. In the third quarter, Oscar Health reported a smaller-than-expected loss with GAAP EPS of $0.53 versus consensus $0.58, even as revenue of $2.99 billion came in below estimates of $3.08 billion.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for Oscar Health was ‘bullish’ amid ‘high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/oscr_ss_png_097e66d206.webp" alt="oscr ss.png" width="918" height="134"><figcaption>OSCR sentiment and message volume as of February 9 | Source: Stocktwits</figcaption></figure>One user noted that “The company has a history of surpassing EPS expectations 75% of the time over the past year.”<stembedurl>https://stocktwits.com/mikesterz7/message/644521250</stembedurl>Another user said, “OSCR feels priced for bad news already. Expectations are low, sentiment is washed out, and management has been executing quietly. Doesn’t need a blowout — a clean beat + solid guidance is enough to re-rate this. Staying long and letting earnings do the talking. “<stembedurl>https://stocktwits.com/Thekiss320/message/644517824</stembedurl>OSCR stock has declined 14% over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Oscar Health, Inc. is displayed on a smartphone screen on May 04, 2025, in Chongqing, China.  (Photo illustration by Cheng Xin/Getty Images)

OSCR Stock Snaps 6-Day Slide Ahead Of Q4 Results: Can The Rebound Survive Post-ACA Subsidy Fears?

Oscar’s earnings come as ACA enrollment shows early signs of cooling.

Equity

State of Michigan Retirement System Makes New Investment in Oscar Health, Inc. $OSCR

State of Michigan Retirement System bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and...

Oscar Health (NYSE:OSCR) Shares Gap Down - Here's What Happened

Oscar Health (NYSE:OSCR) Shares Gap Down - Here's What Happened...

Noteworthy Tuesday Option Activity: OSCR, WMB, ABNB

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Oscar Health Inc (Symbol: OSCR), where a total of 41,146 contracts have traded so far...

Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note

In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $14, indicating a -2.44% shift from the previous trading day.

Q Fund Management Hong Kong Ltd Invests $5.94 Million in Oscar Health, Inc. $OSCR

Q Fund Management Hong Kong Ltd bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and...

Oscar Health, Inc. (OSCR) Stock Slides as Market Rises: Facts to Know Before You Trade

Oscar Health, Inc. (OSCR) closed at $14.88 in the latest trading session, marking a -5.22% move from the prior day.

Oscar Health, Inc. (NYSE:OSCR) Given Consensus Rating of "Reduce" by Brokerages

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has earned an average recommendation of "Reduce" from the ten ratings firms that are presently covering the company, MarketBeat.com reports. Two...

Notable Wednesday Option Activity: OSCR, FCX, HAL

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Oscar Health Inc (Symbol: OSCR), where a total of 45,878 contracts have traded so far...

Oscar Health (NYSE:OSCR) Shares Down 5.1% - Here's Why

Oscar Health (NYSE:OSCR) Stock Price Down 5.1% - Here's What Happened...

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

OSCR health stock price, news, financials, forum, discussion, community insights, and trading ideas, Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

OSCR Health Stock Price Today, News, Analysis and Trading Ideas

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

OSCR
Oscar Health Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OSCR News

OSCROscar Health Inc - Ordinary Shares - Class A